Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Autotransfusion Devices Market: By Product Type: Autotransfusion Systems, Consumables and Accessories; By Application: Cardiovascular Surgeries, Orthopaedic Surgeries, Others; By End-Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Autotransfusion Devices Market Outlook
The global autotransfusion devices market reached a value of about USD 269.66 million in 2021. The market is further estimated to grow at a CAGR of 5.00% in the forecast period of 2022-2027 to reach a value of around USD 360.7 million by 2027.
Rising Demand for Intraoperative Autotransfusion Systems to Propel the Market Growth of Autotransfusion Devices
Based on product type, the demand for intraoperative transfusion systems is witnessing a healthy growth. The intraoperative autotransfusion systems enable the collection of a patient's own blood during a surgery or an invasive procedure where the blood loss can be anticipated or unpredictable. The washed red blood cells are then transfused back to the patient’s body after the removal of discarded products like platelets and anticoagulants. It decreases net perioperative blood loss, helps maintain postoperative haemoglobin, reduces the risk of blood-borne diseases, reduces patient care costs, eliminates the risk of receiving wrong blood due to human or clerical error, and helps recycle lost blood products. Moreover, the patient's own fresh red blood cells are known to maintain their flexibility in the microcirculation, thereby becoming immediately active in tissue oxygenation. The government initiatives towards developing national frameworks that would maximise patient safety during intraoperative autotransfusion are likely to bolster the autotransfusion devices market growth over the forecast period.
Market Segmentation
Autotransfusion devices refer to equipment that helps in the autotransfusion of blood, including the offering of autologous blood to a patient during surgical or invasive procedures. The autologous blood is collected from a patient during heavy blood loss, and the washed red blood cells are re-infused into the body. The autotransfusion of blood is safe, cost-effective, and reduces the dependency on allogenic blood.
The market for autotransfusion devices, by product type, is divided into:
- Autotransfusion Systems
- Intraoperative Autotransfusion Systems
- Post-Operative Autotransfusion Systems
- Dual-Mode Autotransfusion Systems
- Consumables and Accessories
Based on application, the market is segmented into:
- Cardiovascular Surgeries
- Orthopaedic Surgeries
- Neurological Surgeries
- Obstetrics and Gynaecology Surgeries
- Others
On the basis of end-use, the market is classified into:
- Hospitals
- Speciality Clinics
- Others
The regional markets for autotransfusion devices can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Rising Surgeries and the Exceptional Benefits of the Devices to Drive the Market Growth of Autotransfusion Devices
The increasing number of surgeries conducted worldwide, owing to the developing healthcare infrastructure and the rapid diagnosis of diseases, leads to the increased demand for blood for performing these procedures, which is driving the autotransfusion devices market growth. The rising incidences of haemorrhage and the increasing need for safe and sufficient blood and blood products to save lives are propelling the demand for these devices. The autotransfusion of blood offers multiple advantages over donated blood, such as it is cost-effective, does not lose its fluidity and function during storage, reduces the risk of infections and complications, eliminates the dependency on blood bank reserves, and reduces morbidity rate. Additionally, it is considered a safe procedure, owing to the advancements in filtration and sterile techniques. The availability of different types of autotransfusion systems, such as in-line, self-filling, and continuous, is aiding the market development. Continuous autotransfusion is faster, requires less staffing involvement, and poses a reduced risk of contamination. The strong presence of autotransfusion device manufacturers and their initiatives to launch sophisticated, effective, and automated devices are expected to augment the market growth over the forecast period.
Key Players in the Global Market for Autotransfusion Devices
The report gives a detailed analysis of the following key players in the global autotransfusion devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- LivaNova PLC
- Haemonetics Corporation
- Medtronic plc
- Fresenius SE & Co. KGaA
- Becton, Dickinson, and Company (BD)
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Autotransfusion Devices Market Analysis
8.1 Key Industry Highlights
8.2 Global Autotransfusion Devices Historical Market (2017-2021)
8.3 Global Autotransfusion Devices Market Forecast (2022-2027)
8.4 Global Autotransfusion Devices Market by Product Type
8.4.1 Autotransfusion Systems
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.1.4 Breakup by Type
8.4.1.4.1 Intraoperative Autotransfusion Systems
8.4.1.4.2 Post-Operative Autotransfusion Systems
8.4.1.4.3 Dual-Mode Autotransfusion Systems
8.4.2 Consumables and Accessories
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Autotransfusion Devices Market by Application
8.5.1 Cardiovascular Surgeries
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Orthopaedic Surgeries
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Neurological Surgeries
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Obstetrics and Gynecological Surgeries
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Others
8.6 Global Autotransfusion Devices Market by End-Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Speciality Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Others
8.7 Global Autotransfusion Devices Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 LivaNova PLC
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Haemonetics Corporation
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Medtronic plc
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Fresenius SE & Co. KGaA
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Becton, Dickinson, and Company (BD)
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Autotransfusion Devices Market: Key Industry Highlights, 2017 and 2027
2. Global Autotransfusion Devices Historical Market: Breakup by Product Type (USD Million), 2017-2021
3. Global Autotransfusion Devices Market Forecast: Breakup by Product Type (USD Million), 2022-2027
4. Global Autotransfusion Devices Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Autotransfusion Devices Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Autotransfusion Devices Historical Market: Breakup by End-Use (USD Million), 2017-2021
7. Global Autotransfusion Devices Market Forecast: Breakup by End-Use (USD Million), 2022-2027
8. Global Autotransfusion Devices Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Autotransfusion Devices Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Autotransfusion Devices Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Autotransfusion Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Autotransfusion Devices Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Autotransfusion Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Autotransfusion Devices Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Autotransfusion Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Autotransfusion Devices Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Autotransfusion Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Autotransfusion Devices Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Autotransfusion Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Autotransfusion Devices Market Structure
Key Questions Answered in the Report
In 2021, the global autotransfusion devices market attained a value of nearly USD 269.66 million.
The market is assessed to grow at a CAGR of 5.00% between 2022 and 2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach almost USD 360.7 million by 2027.
The major market drivers include the developing healthcare infrastructure, rapid diagnosis of diseases, rising incidences of haemorrhage, increasing need for safe and sufficient medical procedures, availability of different types of autotransfusion systems and their exceptional benefits, need to reduce the dependency on blood bank reserves, and government initiatives to maximise patient safety during intraoperative autotransfusion of blood.
The key trends guiding the growth of the market include the rising number of surgeries worldwide, development of efficient and automated autotransfusion devices, and the increasing penetration of market players in emerging nations.
The major regions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant product types of autotransfusion devices include autotransfusion systems, and consumables and accessories.
The different applications of autotransfusion devices include cardiovascular surgeries, orthopaedic surgeries, neurological surgeries, and obstetrics and gynaecology surgeries, among others.
The major end uses of autotransfusion devices include hospitals, and speciality clinics, among others.
The major players in the market are LivaNova PLC, Haemonetics Corporation, Medtronic plc, Fresenius SE & Co. KGaA, and Becton, Dickinson, and Company (BD), among others.
Analyst Review
The global autotransfusion devices market attained a value of nearly USD 269.66 million in 2021, driven by the rising number of surgeries worldwide and the exceptional benefits of autotransfusion devices. Aided by the development of efficient and automated autotransfusion devices, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5.00%. The market is estimated to reach about USD 360.7 million by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The market for autotransfusion devices, by product type, is divided into autotransfusion systems, and consumables and accessories. Based on application, the market is segmented into cardiovascular surgeries, orthopaedic surgeries, neurological surgeries, and obstetrics and gynaecology surgeries, among others. On the basis of end-use, the market is classified into hospitals, and speciality clinics, among others. The major regional markets for autotransfusion devices are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include LivaNova PLC, Haemonetics Corporation, Medtronic plc, Fresenius SE & Co. KGaA, and Becton, Dickinson, and Company (BD), among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The rising cases of chronic diseases drove the global healthcare regulatory affairs outsourcing market in the historical period. Aided by the increase in demand for drugs and medical devices at a lowe...
The global electronic health records (EHR) market attained a value of nearly USD 29.6 billion in 2021, driven by the rapid digitalisation of the healthcare infrastructure to improve patient care. Aide...
The global energy recovery ventilator market was driven by the increased emphasis on air quality in the historical period. Aided by the growing number of green buildings and rising awareness amongst p...
The global cerebral somatic oximeters market was driven by the increasing popularity of cerebral devices in the historical period. Aided by the rising demand for superior quality healthcare treatment ...
The global blood pressure monitors market attained a value of nearly USD 1.6 billion in 2021, driven by the growing demand for proactive monitoring of hypertension. Aided by the rising awareness regar...
NEWSLETTER